Kane Biotech Inc V.KNE

So, what's next ?

[RoyMax123]

The maturity date of the amended credit facility have expired again and dead silence from the Co.
 

This is getting beyond ridiculous...

[francoisl13]

Next 'things' to look for are; 1. Credit facility needs to be re-negotiated; 2. Update on the animal division sales/spin-off/etc...; 3. DispersinB trials  Best scenario would be to sell the animal division (or make a deal with a third-party) that will bring enough money in the bank to prevent another dilutive deal with Pivot Financial, will see. GLTA

[francoisl13]

Very quiet since the last financials. No news or communication regarding any of the points mentioned in my previous post. The only thing we know is that KNE is producing roughly 2000 oz of Revyve product per month to support Progenacare efforts in the USA. At the price point mentioned in their presentation, this is roughly a sales value of 40K but at this point in the sales development of this